Press release
Prescription Drugs Market Growth | Trends, Top Drugs & Industry Forecast 2025 | Top key players - Sanofi, Pfizer Inc, GlaxoSmithKline plc.
The Global Prescription Drugs Market is expected to reach at a Significant CAGR during the forecast period 2024-2031.Prescription Drugs Market report, published by DataM Intelligence, delivers detailed insights and analysis on major market trends, growth prospects, and emerging challenges. With a strong focus on providing actionable intelligence, DataM Intelligence enables businesses to make well-informed decisions and maintain a competitive edge. By blending both qualitative and quantitative research approaches, the company offers thorough reports that support clients in navigating complex market environments, driving strategic expansion, and capitalizing on new opportunities in today's rapidly evolving global landscape.
The Prescription Drugs Market includes medications that require a doctor's authorization to be dispensed. These drugs are used to treat a wide range of health conditions and are regulated for safety and effectiveness. The market is driven by rising chronic diseases, aging populations, and medical advancements, making prescription medications a vital part of modern healthcare systems worldwide.
Request a Free Sample PDF of This Report (Corporate Email IDs Receive Priority Service): https://datamintelligence.com/download-sample/prescription-drugs-market?sz
Market opportunities and Growth Drivers:
The rising prevalence of chronic diseases
Chronic diseases like diabetes, heart conditions, respiratory problems, and cancer are becoming increasingly common-and they often require long-term or even lifelong care. As a result, more people are relying on prescription medications to manage their health. Contributing to this rise are modern lifestyle factors such as lack of physical activity, poor eating habits, and exposure to environmental stressors, all of which are fueling conditions like obesity, type 2 diabetes, and heart disease.
Prescription Drugs Market Recent Development:
Amazon Expands Into Prescription Drug Market
In January 2023, Amazon took another big step into the healthcare space by launching a new prescription drug program. The service allows subscribers to access as many medications as they need for a flat monthly fee. This move is part of Amazon's ongoing effort to compete with traditional drugstores and reshape how people access healthcare, as tech giants continue to broaden their role in the medical field.
Pfizer Seeks FDA Approval for COVID-19 Treatment
In June 2022, Pfizer submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its antiviral treatment, PAXLOVID. The company is seeking approval for use in patients at high risk of developing severe COVID-19 symptoms. Currently, PAXLOVID can only be prescribed by licensed healthcare professionals-such as doctors, nurse practitioners, and physician assistants-who are authorized to prescribe medications in its class.
List of the Key Players in the Prescription Drugs Market:
F. Hoffmann-La Roche Ltd, Mylan N.V., Teva Pharmaceutical Industries Ltd, Sanofi, Pfizer Inc, GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., Allergan, Dr. 'Reddy's Laboratories Ltd among others.
Research Process:
Both primary and secondary data sources have been used in the global Prescription Drugs Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/prescription-drugs-market
Segment Covered in the Prescription Drugs Market:
By Type: Branded, Generic.
By Therapy Area: Oncology, Immunology, Ophthalmology, Respiratory, Gastroenterology, Gynecology, Others.
By Route of Administration: Oral, Topical, Parenteral, Others.
By Sales Channel: Online, Offline.
Regional Analysis for Prescription Drugs Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
People Also Ask:
Most Frequently Asked Questions in the Prescription Drugs Market Research Industry:
➠ What are the global figures for sales, production, consumption, imports, and exports in the Prescription Drugs market?
➠ Who are the top manufacturers in the global Prescription Drugs industry, and what is their current status in terms of production capacity, output, sales performance, pricing structure, cost analysis, profit margins, and overall revenue?
➠ What key opportunities are available for vendors in the Prescription Drugs market, and what challenges are they likely to encounter?
➠ Which application areas, end-user segments, or product types are projected to experience significant growth, and how is the market share distributed among them?
➠ What are the major drivers and barriers influencing the growth trajectory of the Prescription Drugs market?
➠ What are the primary sales, marketing, and distribution strategies used across the global Prescription Drugs industry landscape?
Browse More Reports: https://www.datamintelligence.com/research-report/prescription-drugs-market
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Prescription Drugs Market Growth | Trends, Top Drugs & Industry Forecast 2025 | Top key players - Sanofi, Pfizer Inc, GlaxoSmithKline plc. here
News-ID: 4009099 • Views: …
More Releases from DataM Intelligence 4Market Research

Benzene Market Expands with Industrial Growth and Chemical Demand | Trends & For …
The Global Benzene Market reached USD 64 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 81 billion by 2031. The market is growing at a CAGR of 3.0% during the forecast period 2024-2031.
The latest Benzene market research report from DataM Intelligence delivers a comprehensive analysis of the global Benzene Market landscape, highlighting emerging trends, market size, competitive dynamics, and key growth drivers. This…

Global Carboxylic Acids Market Booms Amid Rising Industrial & Pharmaceutical App …
The Global Carboxylic Acids Market is estimated to reach at a CAGR of 3.7% during the forecast period (2024-2031).
The latest Carboxylic Acids market research report from DataM Intelligence delivers a comprehensive analysis of the global Carboxylic Acids Market landscape, highlighting emerging trends, market size, competitive dynamics, and key growth drivers. This high-impact report offers strategic insights for investors, marketers, and decision-makers looking to capitalize on current and future market opportunities.
Download…

Global Mining Equipment Market Surges Amid Automation & Green Tech Demand | Fore …
The Global Mining Equipment Market reached US$ 24.5 billion in 2023 and is expected to reach US$ 34.0 billion by 2031, growing with a CAGR of 4.2% during the forecast period 2024-2031.
The latest Mining Equipment market research report from DataM Intelligence delivers a comprehensive analysis of the global Mining Equipment Market landscape, highlighting emerging trends, market size, competitive dynamics, and key growth drivers. This high-impact report offers strategic insights for…

Microspheres Market Set to Soar: Innovations in Medical, Cosmetics, and 3D Print …
The Global Microspheres Market is expected to reach at a CAGR of 8.0% during the forecasting period (2024-2031).
The latest Microspheres market research report from DataM Intelligence delivers a comprehensive analysis of the global Microspheres Market landscape, highlighting emerging trends, market size, competitive dynamics, and key growth drivers. This high-impact report offers strategic insights for investors, marketers, and decision-makers looking to capitalize on current and future market opportunities.
Download exclusive insights with…
More Releases for Drug
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Indispensable Advent of Microcapsules
1.1 Trajectory of Microencapsulation
1.2 Why and wherefores for Microencapsulation
2. Characterization of Microcapsules
2.1 Composition of Microcapsules
2.2 Parameters Influencing Microcapsules
3. Engineering Technology of Microcapsules
3.1 Physical Manufacturing Technologies
3.2 Physicochemical and Chemical Technologies
4. Applicability of Microcapsules
4.1 Microcapsules in Pharmaceuticals
4.2 Microcapsules in Nutraceuticals
…
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug
European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning…
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June.
The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug…